InterMune Says Lung Disease Drug Succeeds in Late-Stage Study

InterMune said its experimental drug for lung disease succeeded in a late-stage trial, raising expectations that the treatment could be eventually be approved by the FDA



from WSJ.com: US Business http://ift.tt/MZmQpp

via IFTTT